斯科波胺会导致类似妄想的脑网络功能障碍和可逆性认知障碍,而不会导致神经元损失
Qing Wang1, Xiang Zhang1, Yu-Jie Guo1
1Department of Geriatrics and State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Zoological research
|June 14, 2023
概括
这项研究比较了三只小鼠妄症模型,发现斯科波胺 (Scop) 注射有效地模仿了类似妄症的症状,包括认知障碍和多动性,为妄症机制提供了洞察力.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 药理学 药理学是指药理学的学科.
背景情况:
- 痴呆症是一种严重的急性神经精神综合征,在老年人中,与痴呆症风险有关.
- 已经确立的妄想动物模型很少,阻碍了机理学理解.
- 需要临床相关的风险因素来开发可靠的妄想模型.
研究的目的:
- 为了比较三种不同的小鼠模型,通过麻醉诱导的妄想与手术 (AS),全身炎症和神经传递调节.
- 找出一个合适的动物模型,复制类似妄想的表型和潜在机制.
主要方法:
- 在小鼠中使用细菌脂聚糖 (LPS),胺 (Scop) 和手术麻醉 (AS) 诱导类似狂妄状态.
- 评估神经元活动在 Delirium 相关的大脑网络.
- 评估认知功能,行为和海马突触功能.
主要成果:
- 无论是LPS还是Scop,都降低了与妄相关的大脑网络中的神经元活动.
- 斯科波胺 (Scop) 诱导反映了在人类狂妄症患者中观察到的神经元活动减少模式.
- 扫描注射导致可逆性认知障碍和多动性,影响了海马突触功能,但没有胆固醇神经元损失.
结论:
- 斯科波胺 (Scop) 注射作为模仿小鼠 Delirium-like 现象型的可行模型.
- 这种模型提供了对妄发作和进展背后的机制有价值的见解.
- 使用这种模型进行进一步的研究可以阐明痴呆症的复杂病理生理学及其与痴呆症的联系.
相关概念视频
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
165
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
165
01:30Positive Symptoms of Schizophrenia: Hallucinations and Delusions
178
Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
178
01:26Psychosis: Goals of Pharmacotherapy
172
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
172
01:26Alzheimer's Disease: Overview
532
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
532
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
765
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
765